302 related articles for article (PubMed ID: 33854594)
1. Centromere Protein F (
Huang Y; Chen X; Wang L; Wang T; Tang X; Su X
J Cancer; 2021; 12(10):2933-2951. PubMed ID: 33854594
[TBL] [Abstract][Full Text] [Related]
2. CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.
Huang YG; Li D; Wang L; Su XM; Tang XB
J Transl Med; 2022 Feb; 20(1):78. PubMed ID: 35123514
[TBL] [Abstract][Full Text] [Related]
3. Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways.
Chen H; Wu F; Xu H; Wei G; Ding M; Xu F; Deivasigamani A; Zhou G; Hui KM; Xia H
Cancer Gene Ther; 2022 Jul; 29(7):1033-1042. PubMed ID: 34857915
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.
Dai Y; Liu L; Zeng T; Zhu YH; Li J; Chen L; Li Y; Yuan YF; Ma S; Guan XY
Biochem Biophys Res Commun; 2013 Jul; 436(4):711-8. PubMed ID: 23791740
[TBL] [Abstract][Full Text] [Related]
5. Expression Levels of Three Key Genes CCNB1, CDC20, and CENPF in HCC Are Associated With Antitumor Immunity.
Si T; Huang Z; Jiang Y; Walker-Jacobs A; Gill S; Hegarty R; Hamza M; Khorsandi SE; Jassem W; Heaton N; Ma Y
Front Oncol; 2021; 11():738841. PubMed ID: 34660300
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.
Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q
J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma.
Li X; Li Y; Xu A; Zhou D; Zhang B; Qi S; Chen Z; Wang X; Ou X; Cao B; Qu C; Huang J
Oncoimmunology; 2021; 10(1):1992104. PubMed ID: 34676150
[TBL] [Abstract][Full Text] [Related]
8. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.
Wang XK; Liao XW; Yang CK; Liu ZQ; Han QF; Zhou X; Zhang LB; Deng T; Gong YZ; Huang JL; Huang R; Han CY; Yu TD; Su H; Ye XP; Peng T; Zhu GZ
J Cell Physiol; 2020 Oct; 235(10):7003-7017. PubMed ID: 32037547
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
10. RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma.
Cui F; Wang W; Zhuang C; He D; Wang P
Transl Cancer Res; 2024 Apr; 13(4):1606-1622. PubMed ID: 38737697
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer.
Sun J; Huang J; Lan J; Zhou K; Gao Y; Song Z; Deng Y; Liu L; Dong Y; Liu X
Cancer Cell Int; 2019; 19():264. PubMed ID: 31632198
[TBL] [Abstract][Full Text] [Related]
13. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
Front Oncol; 2021; 11():721644. PubMed ID: 34631549
[TBL] [Abstract][Full Text] [Related]
14. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Wu Z; He L; Yang L; Fang X; Peng L
Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
[No Abstract] [Full Text] [Related]
15. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL
Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841
[TBL] [Abstract][Full Text] [Related]
16.
Gao Y; Li Y; Song Z; Jin Z; Li X; Yuan C
J Oncol; 2022; 2022():6509028. PubMed ID: 35847356
[TBL] [Abstract][Full Text] [Related]
17. [Construction of a stable centromere protein F overexpression cell model of hepatocellular carcinoma using CRISPR activation system].
Qi S; Li X; Zhou D; Huang J
Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3738-3746. PubMed ID: 37805850
[TBL] [Abstract][Full Text] [Related]
18. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
Tang M; Liao M; Ai X; He G
Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
[TBL] [Abstract][Full Text] [Related]
19. SMG9 Serves as an Oncogene to Promote the Tumor Progression
Jin X; Yin J; Zhu H; Li W; Yu K; Liu M; Zhang X; Lu M; Wan Z; Huang X
Front Pharmacol; 2021; 12():701454. PubMed ID: 34456727
[No Abstract] [Full Text] [Related]
20.
Xie X; Jiang S; Li X
Front Oncol; 2021; 11():621373. PubMed ID: 33767990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
